T3 Pharmaceuticals

About:

T3 Pharmaceuticals is to improve the lives of cancer patients with highly innovative treatments.

Website: http://www.t3pharma.com

Twitter/X: PharmaT3

Top Investors: Innosuisse, Boehringer Ingelheim Venture Fund, Wille Finance, Reference Capital SA, Swiss Federal Commission for Innovation and Technology

Description:

The vision of T3 Pharmaceuticals is to improve the lives of cancer patients with highly innovative treatments. Despite significant advances of classical therapies, there remains a high need for novel and innovative medicines to treat cancer. T3 Pharmaceuticals is dedicated to fill this gap by developing highly specific and efficient treatments using live bacteria.

Total Funding Amount:

37M CHF

Headquarters Location:

Basel, Basel-Stadt, Switzerland

Founded Date:

2015-01-01

Contact Email:

info(AT)t3pharma.com

Founders:

Christoph Kasper, Simon J. Ittig

Number of Employees:

1-10

Last Funding Date:

2023-04-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai